Dr. Rozakis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
29111 Center Ridge Rd
Westlake, OH 44145Phone+1 440-777-2667Fax+1 440-835-2266
Education & Training
- Duke University HospitalResidency, Ophthalmology, 1984 - 1987
- Duke University HospitalPost-Doctoral Fellowship, Ophthalmology, 1983 - 1987
- Summa Health System/NEOMEDInternship, Transitional Year, 1982 - 1983
- Weill Cornell MedicineClass of 1982
Certifications & Licensure
- CA State Medical License 2016 - 2026
- WA State Medical License 2023 - 2026
- FL State Medical License 2023 - 2026
- VA State Medical License 2023 - 2026
- OH State Medical License 1987 - 2026
- WI State Medical License 2023 - 2025
- AZ State Medical License 2023 - 2025
- American Board of Ophthalmology Ophthalmology
- Join now to see all
Awards, Honors, & Recognition
- Jose Barraquer Award an international award voted upon by leaders in refractive surgery, 1998
- Health Grades Dr. Rozakis is a Healthgrades Recognized Doctor.
- Early LASIK pioneer 2nd in the world to perform LASIK in the United States
Publications & Presentations
PubMed
- 39 citationsCryotherapy for RetinoblastomaDavid H. Abramson, Robert M. Ellsworth, George W. Rozakis
Archives of Ophthalmology. 1982-08-01 - 3 citationsHalos after PRK.George W Rozakis
Journal of Refractive Surgery. 1997-07-01 - 73 citationsThe Effect of Triamcinolone Acetonide on a Refined Experimental Model of Proliferative VitreoretinopathyD. B. Chandler, George Rozakis, Eugene de Juan, Robert Machemer
American Journal of Ophthalmology. 1985-06-01
Journal Articles
- Preventing Macular Degeneration: A New Theory Pioneering Eye Surgeon Sees Hope for Treating Macular Degeneration with Natural HormonesDebora Yost, Life Extension
Press Mentions
- xR’s Emerging New Therapy to Treat Wet Macular Degeneration Non-Invasively Showing Unprecedented ResultsJanuary 11th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: